Crosstalk between the tumor microenvironment and immune system in pancreatic ductal adenocarcinoma: Potential targets for new therapeutic approaches

Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poor. A pancreatic tumor microenvironment is a dynamic milieu of cellular and acellular elements, and it represents one of the major limitations to chemotherapy efficacy. The continued crosstalk between cancer cells and the surrounding microenvironment causes immunosuppression within pancreatic immune infiltrate increasing tumor aggressiveness. Several potential targets have been identified among tumor microenvironment components, and different therapeutic approaches are under investigation. In this article, we provide a qualitative literature review about the crosstalk between the tumor microenvironment components and immune system in pancreatic cancer. Finally, we discuss potential therapeutic strategies targeting the tumor microenvironment and we show the ongoing trials.

Original languageEnglish
Article number7530619
JournalGastroenterology Research and Practice
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Tumor Microenvironment
Immune System
Adenocarcinoma
gemcitabine
Cellular Microenvironment
Drug Therapy
Therapeutics
Pancreatic Neoplasms
Immunosuppression
Neoplasms
Survival

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Crosstalk between the tumor microenvironment and immune system in pancreatic ductal adenocarcinoma : Potential targets for new therapeutic approaches. / Parente, Paola; Parcesepe, Pietro; Covelli, Claudia; Olivieri, Nunzio; Remo, Andrea; Pancione, Massimo; Latiano, Tiziana Pia; Graziano, Paolo; Maiello, Evaristo; Giordano, Guido.

In: Gastroenterology Research and Practice, Vol. 2018, 7530619, 01.01.2018.

Research output: Contribution to journalReview article

@article{20ff772010ec4b7288ed5449c3268ab8,
title = "Crosstalk between the tumor microenvironment and immune system in pancreatic ductal adenocarcinoma: Potential targets for new therapeutic approaches",
abstract = "Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poor. A pancreatic tumor microenvironment is a dynamic milieu of cellular and acellular elements, and it represents one of the major limitations to chemotherapy efficacy. The continued crosstalk between cancer cells and the surrounding microenvironment causes immunosuppression within pancreatic immune infiltrate increasing tumor aggressiveness. Several potential targets have been identified among tumor microenvironment components, and different therapeutic approaches are under investigation. In this article, we provide a qualitative literature review about the crosstalk between the tumor microenvironment components and immune system in pancreatic cancer. Finally, we discuss potential therapeutic strategies targeting the tumor microenvironment and we show the ongoing trials.",
author = "Paola Parente and Pietro Parcesepe and Claudia Covelli and Nunzio Olivieri and Andrea Remo and Massimo Pancione and Latiano, {Tiziana Pia} and Paolo Graziano and Evaristo Maiello and Guido Giordano",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/7530619",
language = "English",
volume = "2018",
journal = "Gastroenterology Research and Practice",
issn = "1687-6121",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Crosstalk between the tumor microenvironment and immune system in pancreatic ductal adenocarcinoma

T2 - Potential targets for new therapeutic approaches

AU - Parente, Paola

AU - Parcesepe, Pietro

AU - Covelli, Claudia

AU - Olivieri, Nunzio

AU - Remo, Andrea

AU - Pancione, Massimo

AU - Latiano, Tiziana Pia

AU - Graziano, Paolo

AU - Maiello, Evaristo

AU - Giordano, Guido

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poor. A pancreatic tumor microenvironment is a dynamic milieu of cellular and acellular elements, and it represents one of the major limitations to chemotherapy efficacy. The continued crosstalk between cancer cells and the surrounding microenvironment causes immunosuppression within pancreatic immune infiltrate increasing tumor aggressiveness. Several potential targets have been identified among tumor microenvironment components, and different therapeutic approaches are under investigation. In this article, we provide a qualitative literature review about the crosstalk between the tumor microenvironment components and immune system in pancreatic cancer. Finally, we discuss potential therapeutic strategies targeting the tumor microenvironment and we show the ongoing trials.

AB - Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poor. A pancreatic tumor microenvironment is a dynamic milieu of cellular and acellular elements, and it represents one of the major limitations to chemotherapy efficacy. The continued crosstalk between cancer cells and the surrounding microenvironment causes immunosuppression within pancreatic immune infiltrate increasing tumor aggressiveness. Several potential targets have been identified among tumor microenvironment components, and different therapeutic approaches are under investigation. In this article, we provide a qualitative literature review about the crosstalk between the tumor microenvironment components and immune system in pancreatic cancer. Finally, we discuss potential therapeutic strategies targeting the tumor microenvironment and we show the ongoing trials.

UR - http://www.scopus.com/inward/record.url?scp=85062840522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062840522&partnerID=8YFLogxK

U2 - 10.1155/2018/7530619

DO - 10.1155/2018/7530619

M3 - Review article

AN - SCOPUS:85062840522

VL - 2018

JO - Gastroenterology Research and Practice

JF - Gastroenterology Research and Practice

SN - 1687-6121

M1 - 7530619

ER -